TD ASSET MANAGEMENT INC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,323,848
-51.2%
59,074
-11.3%
0.00%
-33.3%
Q2 2023$2,710,127
+39.0%
66,637
+65.6%
0.00%
+50.0%
Q1 2023$1,949,758
+170.3%
40,251
+113.0%
0.00%
+100.0%
Q4 2022$721,298
-55.5%
18,897
-41.3%
0.00%
-50.0%
Q3 2022$1,622,000
+29.3%
32,213
+2.9%
0.00%
+100.0%
Q2 2022$1,254,000
-6.9%
31,313
-13.3%
0.00%0.0%
Q1 2022$1,347,000
-27.1%
36,114
-22.2%
0.00%
-50.0%
Q4 2021$1,849,000
+18.5%
46,434
+10.8%
0.00%0.0%
Q3 2021$1,560,000
-2.9%
41,9160.0%0.00%0.0%
Q2 2021$1,607,000
-22.5%
41,916
-4.3%
0.00%0.0%
Q1 2021$2,074,000
-18.7%
43,805
+4.8%
0.00%
-33.3%
Q4 2020$2,551,000
+38.1%
41,805
+5.8%
0.00%0.0%
Q3 2020$1,847,000
-12.1%
39,498
-4.6%
0.00%0.0%
Q2 2020$2,101,000
+58.1%
41,398
+38.9%
0.00%
+50.0%
Q1 2020$1,329,000
-65.3%
29,798
-62.6%
0.00%
-66.7%
Q4 2019$3,825,000
+36.9%
79,631
-3.7%
0.01%
+50.0%
Q3 2019$2,795,000
-24.3%
82,656
+0.8%
0.00%
-33.3%
Q2 2019$3,691,000
+24.1%
82,031
+3.8%
0.01%
+20.0%
Q1 2019$2,975,000
+30.5%
79,031
+19.0%
0.01%
+25.0%
Q4 2018$2,280,000
-14.0%
66,431
+17.7%
0.00%0.0%
Q3 2018$2,652,000
+430.4%
56,431
+280.5%
0.00%
+300.0%
Q2 2018$500,00014,8310.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders